KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Change in Receivables (2017 - 2025)

Cardlytics (CDLX) has disclosed Change in Receivables for 9 consecutive years, with -$5.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables fell 1516.26% year-over-year to -$5.8 million, compared with a TTM value of -$20.6 million through Dec 2025, down 65.18%, and an annual FY2025 reading of -$20.6 million, down 65.18% over the prior year.
  • Change in Receivables was -$5.8 million for Q4 2025 at Cardlytics, down from -$4.6 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $27.2 million in Q4 2021 and bottomed at -$21.4 million in Q1 2023.
  • Average Change in Receivables over 5 years is $353350.0, with a median of -$1.9 million recorded in 2021.
  • The sharpest move saw Change in Receivables soared 176.09% in 2023, then plummeted 1516.26% in 2025.
  • Year by year, Change in Receivables stood at $27.2 million in 2021, then dropped by 27.78% to $19.6 million in 2022, then dropped by 4.65% to $18.7 million in 2023, then tumbled by 97.8% to $412000.0 in 2024, then tumbled by 1516.26% to -$5.8 million in 2025.
  • Business Quant data shows Change in Receivables for CDLX at -$5.8 million in Q4 2025, -$4.6 million in Q3 2025, and -$2.6 million in Q2 2025.